Disclosure under Corporate Insolvency Resolution Process (CIRP) pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd, currently under Corporate Insolvency Resolution Process (CIRP), informed the stock exchange that its Resolution Plan, already approved by the Committee of Creditors (CoC) on May 24, 2025, was listed for consideration and approval before the NCLT Mumbai Bench-VI on June 5, 2025. The Resolution Professional, Roshen Chordiya, signed the disclosure. The next hearing for the plan and related proceedings is scheduled for July 1, 2025. The company stated it will keep stakeholders informed of further developments.
The stock remains under CIRP and outcome remains uncertain until the NCLT formally approves the Resolution Plan. Shareholders face continued risk of dilution or restructuring under the IBC framework, with a key milestone (NCLT approval) pending on July 1, 2025.